Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dorothy H Crawford

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
The Lancet. Oncology|March 3, 2007
How to kill two herpes viruses with one stoneDorothy H Crawford
Blood|October 20, 2005
Epstein-Barr virus: the impact of scientific advances on clinical practiceHilary Williams, Dorothy H Crawford
The Lancet. Infectious Diseases|March 5, 2003
Epstein-Barr virus-recent advancesKaren F Macsween, Dorothy H Crawford
Blood Reviews|June 9, 2004
Epstein-Barr virus-specific cytotoxic T-lymphocytes for adoptive immunotherapy of post-transplant lymphoproliferative diseaseDavid M Burns, Dorothy H Crawford
European Journal of Cancer (Oxford, England : 1990)|August 19, 2004
Viruses and tumours--an updateSimon J Talbot, Dorothy H Crawford
The New England Journal of Medicine|September 18, 2007
Human papillomavirus and oropharyngeal cancerHilary Williams, Craig D Higgins, Dorothy H Crawford
Journal of Neurovirology|June 19, 2004
Effects of human immunodeficiency virus encephalitis and drug abuse on the B lymphocyte population of the brainIain C Anthony, Dorothy H Crawford, Jeanne E Bell
Transplantation|July 8, 2010
Allogeneic T-cell therapy for Epstein-Barr virus-positive posttransplant lymphoproliferative disease: long-term follow-upTanzina Haque, Karen A McAulay, Deirdre Kelly, et al.
Blood|August 5, 2005
Interferon gamma (IFN-gamma) polymorphism in posttransplantation lymphoproliferative diseaseRanjit V Thomas, Karen McAulay, Craig Higgins, et al.
Journal of Medical Virology|December 25, 2010
Soluble CD30: a serum marker for Epstein-Barr virus-associated lymphoproliferative diseasesTanzina Haque, Turren Chaggar, Jenna Schafers, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
The Lancet. Oncology|March 3, 2007
How to kill two herpes viruses with one stoneDorothy H Crawford
Blood|October 20, 2005
Epstein-Barr virus: the impact of scientific advances on clinical practiceHilary Williams, Dorothy H Crawford
The Lancet. Infectious Diseases|March 5, 2003
Epstein-Barr virus-recent advancesKaren F Macsween, Dorothy H Crawford
Blood Reviews|June 9, 2004
Epstein-Barr virus-specific cytotoxic T-lymphocytes for adoptive immunotherapy of post-transplant lymphoproliferative diseaseDavid M Burns, Dorothy H Crawford
European Journal of Cancer (Oxford, England : 1990)|August 19, 2004
Viruses and tumours--an updateSimon J Talbot, Dorothy H Crawford
The New England Journal of Medicine|September 18, 2007
Human papillomavirus and oropharyngeal cancerHilary Williams, Craig D Higgins, Dorothy H Crawford
Journal of Neurovirology|June 19, 2004
Effects of human immunodeficiency virus encephalitis and drug abuse on the B lymphocyte population of the brainIain C Anthony, Dorothy H Crawford, Jeanne E Bell
Transplantation|July 8, 2010
Allogeneic T-cell therapy for Epstein-Barr virus-positive posttransplant lymphoproliferative disease: long-term follow-upTanzina Haque, Karen A McAulay, Deirdre Kelly, et al.
Blood|August 5, 2005
Interferon gamma (IFN-gamma) polymorphism in posttransplantation lymphoproliferative diseaseRanjit V Thomas, Karen McAulay, Craig Higgins, et al.
Journal of Medical Virology|December 25, 2010
Soluble CD30: a serum marker for Epstein-Barr virus-associated lymphoproliferative diseasesTanzina Haque, Turren Chaggar, Jenna Schafers, et al.
Pageof 4